Related Experiment Video
Updated: Apr 18, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Defective skeletal mineralization in pediatric CKD
1Pediatric Nephrology, David Geffen School of Medicine at UCLA, A2-383 MDCC, 650 Charles Young Dr, Los Angeles, CA, 93001-1835, USA, KWesseling@mednet.ucla.edu.
Insights
Pediatric chronic kidney disease (CKD) causes skeletal mineralization defects early on, impacting bone health. Current treatments for secondary hyperparathyroidism don't fix these defects and may harm bone cells.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Bone Biology
- Mineral Metabolism
Background:
- Traditional diagnosis of renal osteodystrophy focused on bone turnover.
- Pediatric chronic kidney disease (CKD) is linked to prevalent skeletal mineralization abnormalities.
- These abnormalities contribute to significant skeletal morbidities in children with CKD.
Purpose of the Study:
- To highlight the prevalence of skeletal mineralization defects in pediatric CKD.
- To investigate the role of osteocyte biology alterations in early CKD.
- To evaluate the effectiveness of current treatments on skeletal mineralization and osteocyte function.
Main Methods:
- Analysis of current data on pediatric CKD and bone health.
- Review of studies on osteocyte protein expression in early CKD.
- Assessment of the impact of 1,25(OH)2vitamin D on skeletal mineralization and osteocyte biology.
Main Results:
- Skeletal mineralization abnormalities are common in pediatric CKD, preceding traditional markers.
- Altered osteocyte biology occurs early in CKD and may cause defective mineralization.
- Current treatments like 1,25(OH)2vitamin D do not correct defective mineralization and may worsen osteocyte biology.
Conclusions:
- Defective skeletal mineralization is a key issue in pediatric CKD, driven by early osteocyte changes.
- Existing treatments for secondary hyperparathyroidism are insufficient for addressing mineralization defects.
- Further research is essential to understand the triggers and therapeutic effects on osteocyte biology and bone mineralization.
Abstract:
Although traditional diagnosis and treatment of renal osteodystrophy focused on changes in bone turnover, current data demonstrate that abnormalities in skeletal mineralization are also prevalent in pediatric chronic kidney disease (CKD) and likely contribute to skeletal morbidities that continue to plague this population. It is now clear that alterations in osteocyte biology, manifested by changes in osteocytic protein expression, occur in early CKD before abnormalities in traditional measures of mineral metabolism are apparent and may contribute to defective skeletal mineralization. Current treatment paradigms advocate the use of 1,25(OH)2vitamin D for the control of secondary hyperparathyroidism; however, these agents fail to correct defective skeletal mineralization and may exacerbate already altered osteocyte biology. Further studies are critically needed to identify the initial trigger for abnormalities of skeletal mineralization as well as the potential effects that current therapeutic options may have on osteocyte biology and bone mineralization.
More Related Videos
Related Concept Videos
What is the Skeletal System?
Chronic Kidney Disease II: Clinical Manifestations
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...

